Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Indian Journal of Pathology & Microbiology|April 21, 2018
Molecular genetics of BCR-ABL1 negative myeloproliferative neoplasms in IndiaNikhil Rabade, P G Subramanian, Rohan Kodgule, et al.
Aesthetic Surgery Journal|November 9, 2022
Evaluation of Breast Implant-Associated Anaplastic Large Cell Lymphoma With Whole Exome and Genome SequencingNeha Akkad, Rohan Kodgule, Eric J Duncavage, et al.
Cancer Research|September 23, 2024
Selective Enhancer Gain-of-Function Deregulates MYC Expression in Multiple MyelomaMahshid Rahmat, Kendell Clement, Jean-Baptiste Alberge, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 13, 2018
Molecular Heterogeneity in Acute Promyelocytic Leukemia - a Single Center Experience from IndiaNikhil Rabade, Goutham Raval, Shruti Chaudhary, et al.
Indian Journal of Pathology & Microbiology|June 21, 2017
An integrated genomic profile that includes copy number alterations is highly predictive of minimal residual disease status in childhood precursor B-lineage acute lymphoblastic leukemiaNikhil Patkar, P G Subramanian, Prashant Tembhare, et al.
The Journal of Molecular Diagnostics : JMD|September 28, 2025
Evaluation of Long-Read Genome Sequencing for Genomic Profiling of Myeloid CancersHaley J Abel, Mohamed Mahgoub, Nidhi Davarapalli, et al.
Blood Cancer Discovery|November 9, 2022
ETV6 Deficiency Unlocks ERG-Dependent Microsatellite Enhancers to Drive Aberrant Gene Activation in B-Lymphoblastic LeukemiaRohan Kodgule, Joshua W Goldman, Alexander C Monovich, et al.
Biorxiv : the Preprint Server for Biology|May 19, 2023
Selective Enhancer Dependencies in MYC -Intact and MYC -Rearranged Germinal Center B-cell Diffuse Large B-cell LymphomaAshwin R Iyer, Aishwarya Gurumurthy, Rohan Kodgule, et al.
Oncotarget|December 20, 2018
Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in NPM1 mutated acute myeloid leukemiaNikhil Patkar, Rohan Kodgule, Chinmayee Kakirde, et al.
Oncotarget|February 8, 2019
Correction: Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in NPM1 mutated acute myeloid leukemiaNikhil Patkar, Rohan Kodgule, Chinmayee Kakirde, et al.
Pageof 2